Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: a cross-sectional study

BMC Pulmonary Medicine

Fawziah Marra³  Anwar H Gilani¹  Rafeeq Alam Khan²  Amber Hanif Palla¹ 

[1] Department of Biological and Biomedical Sciences, Aga Khan University Medical College, Karachi, Pakistan;Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdul-Aziz University for Health Sciences, King Abdul-Aziz Medical City, Jeddah, 21423, KSA;Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

关键词: Pakistan;    Antibiotic prescribing;    McIsaac-modified Centor score;    Pharyngitis;    Antibiotics;   

Others  :  1136307
DOI  :  10.1186/1471-2466-12-70

 received in 2012-05-17, accepted in 2012-10-26,  发布年份 2012

【 摘 要 】

Background

Although Group A beta hemolytic streptococcus (GABHS) can cause bacterial pharyngitis, the most common etiology is viral; despite this viral etiology, antibiotics are commonly prescribed for this infection in industrialized countries. We investigated the prevalence of GABHS in adult pharyngitis patients from lower socioeconomic settings in Karachi, Pakistan, how often antibiotics are prescribed for pharyngitis and if appropriate agents were used in a developing world setting. Finally, we wanted to see the usefulness of modified McIsaac scores in predicting positive cultures.

Methods

Adult patients were recruited from three local hospital outpatient dispensaries (OPDs). All patients aged 14–65 years who were suspected of having bacterial pharyngitis had throat swabs taken. Laboratory results for GABHS pharyngitis were then compared with their prescriptions. Appropriateness (using the World Health Organization’s definition) and type of antibiotic prescribed were assessed.

Results

Of 137 patients, 30 patients each were studied for scores of 0, 1, 2 and 3; 17 patients were studied for score 4. Although 6 (4.4%) patients were GABHS+, for a prevalence of 43.8 per 1000 population, antibiotics were prescribed to 135 patients (98.5%). Of these, only 11.1% received appropriate antibiotics while 88.9% received inappropriate antibiotics. Penicillins were prescribed most (34.1%), especially amoxicillin/clavulanate; followed by macrolides (31.1%), especially the second-generation agents, and fluoroquinolones (14.8%). McIsaac scores were found to be 100% sensitive and 68.7% specific, giving a positive predictive value (PPV) of 12.7% and a negative predictive value (NPV) of 100%.

Conclusions

Antibiotics were prescribed irrationally to adult pharyngitis patients, as most cultures were negative for bacterial infection. McIsaac modification of Centor scores related directly to culture results. We would therefore highly recommend its use to help family physicians make treatment decisions for adult pharyngitis patients.

【 授权许可】

   
2012 Palla et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bertrand E, Gerard R: Comparison of hospital prevalence of rheumatic heart diseases and acute rheumatic arthritis in France and Africa. Arch Mal Coeur Vaiss 1993, 86:291-295.
• [2]Krober MS, Bass JW, Michels GN: Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985, 253:12714.
• [3]Report of a WHO Expert Consultation Geneva, 29 October–1 November 2001. WHO technical report series # 923. Rheumatic fever and Rheumatric heart disease. The role of the microbiology laboratory in the diagnosis of streptococcal infections and rheumatic fever. 2001, 50-51. (http://www.who.int/cardiovascular_diseases/resources/trs923/en/ webcite). PMID: 15382606
• [4]Woods WA, Carter CT, Stack M, et al.: Group A streptococcal pharyngitis in adults 30 to 65 years of age. South Med J 1999, 92(5):491-492.
• [5]Infectious Diseases and Immunization Committee, Canadian Paediatric Society: Group A Streptococcus: a re-emergent pathogen. Can Med Assoc J 1993, 148:1909-1911.
• [6]Gwaltney JM, Bisno AL: Pharyngitis. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th edition. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 2000:656-661.
• [7]Report of the Conference of Experts, The Rational Use of Drugs - Nairobi 25–29 November. Geneva: World health Organization; 1985:338. 1987. http://apps.who.int/medicinedocs/en/m/abstract/Js17054e/ webcite. ISBN 92 4 156105 X
• [8]Bisno AL, Gerber MA, Gwaltney JM Jr, et al.: Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 1997, 25:574-583.
• [9]Cohen ML: Epidemiology of drug resistance: implications for a post antimicrobial era. Science 1992, 257:1050-1055.
• [10]Gonzales R, Steiner JF, Sande MA: Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997, 278:901-904.
• [11]Ayranci U, Akgun Y, Unluoglu I, et al.: Antibiotic prescribing patterns for sore throat infections in a university-based primary care clinic. Ann Saudi Med 2005, 25:22-28.
• [12]Linder JA, Stafford RS: Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989–1999. JAMA 2001, 286:1181-1186.
• [13]Bisno AL: Acute pharyngitis. N Engl J Med 2001, 344:205-211.
• [14]Anonymous. WHO Model Prescribing Information: Drugs Used in the Treatment of Streptococcal Pharyngitis and Prevention of Rheumatic Fever Geneva, World health Organization. 1999. WHO/EDM?PAR/99.1
• [15]Gooch WM 3rd: Alternatives to penicillin in the management of group A streptococcal pharyngitis. Pediatr Ann 1992, 21(12):810-815.
• [16]McIsaac WJ, Goel V: Sore throat practices of Canadian family physicians. Fam Pract 1997, 14:34-39.
• [17]Ebell MH, Smith MA, Barry HC, et al.: The appropriate clinical examination. Does this patient have strep throat? JAMA 2000, 284:2912-2918.
• [18]McIsaac WJ, Goel V, To T, et al.: The validity of a sore throat score in family practice. CMAJ 2000, 163:811-815.
• [19]Centor RM, Witherspoon JM, Dalton HP, et al.: The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981, 1:239-246.
• [20]Cooper RJ, Hoffman JR, Bartlett JG, et al.: Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001, 134:509-517.
• [21]Snow V, Mottur-Pilson C, Cooper RJ, et al.: Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001, 134:506-508.
• [22]Timothy AD, Graham MD: Diagnosis and treatment of pharyngitis in adults. CJEM 2002, 4:429-430.
• [23]Dajani A, Taubert K, Ferrieri P, Peter G, et al.: Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995, 96:758-764.
• [24]Committee on Infectious Diseases: Group A streptococcal infection. In 2000 Red Book. 25th edition. Edited by Pickering LK. Elk Grove Village, IL: American Academy of Pediatrics; 2001:526-536.
• [25]Bisno AL, Gerber MA, Gwaltney JM Jr, et al.: Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 2002, 35:113-125.
• [26]Bisno AL: Diagnosing strep throat in the adult patient: do clinical criteria really suffice? Ann Intern Med 2003, 139:150-151.
• [27]McIsaac WJ, White D, Tannenbaum D, et al.: A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ 1998, 158:75-83.
• [28]Cebul RD, Poses RM: The comparative cost-effectiveness of statistical decision rules and experienced physicians in pharyngitis management. JAMA 1986, 256:3353-3357.
• [29]Cheesbrough M: Examination of throat and mouth specimens. In District Laboratory Practice in Tropical Countries: Pt. 2. Low price ed. United Kingdom, New York USA, Melbourne Australia, Capetown SouthAfrica: Cambridge Univeristy press; 2000:76-79. 157–234
• [30]National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing, 14th informational supplement M100-S14. Wayne: PA:NCCLS; 2004.
• [31]Hayes CS, Williamson H: Management of Group A Beta-Hemolytic Streptococcal Pharyngitis. Am Fam Physician 2001, 63:1557-1565.
• [32]Aalbers J, Brien K, Chan WS, et al.: Predicting streptococcal pharyngitis in adults in primary care: a systematic review of the diagnostic accuracy of symptoms and signs and validation of the Centor score. BMC Medicine 2011, 9:67. BioMed Central Full Text
• [33]Gill JM, Fleishchut P, Haas S, et al.: Infections in Outpatient Settings: A National Ambulatory Network Study. Fam Med 2006, 38:349-54.33.
• [34]Kumarasamy KK, Toleman MA, Walsh TR, et al.: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
• [35]Seckeler MD, Hoke TR: The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011, 3:67-84.